FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Mutual Pharmaceutical Clonidine Hydrochloride Tablets Recall

Clonidine Hydrochloride Tablets, USP, 0

Mutual Pharmaceutical Company, Inc. · Philadelphia, PA

Risk level
Class II
Reported by FDA
Aug 5, 2015
Recall ID
D-1280-2015
Check your lot numberHow we source this data

Summary

Mutual Pharmaceutical recalled Clonidine Hydrochloride Tablets starting Jul 9, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1280-2015 on Aug 5, 2015. Reason: cGMP Deviations; Clonidine hydrochloride drug substance used in the manufacturing of this product, was dispensed in unauthorized rooms by the drug substance manufacturer. Status: Terminated.

Why it was recalled

cGMP Deviations; Clonidine hydrochloride drug substance used in the manufacturing of this product, was dispensed in unauthorized rooms by the drug substance manufacturer

Product description

Clonidine Hydrochloride Tablets, USP, 0.1 mg, packaged in a) 100 count (NDC 53489-215-01) and b) 1000 count (NDC 53489-215-10) HDPE bottles, Rx only, Mutual Pharmaceutical, Philadelphia, PA

Lot numbers, UPCs & expiration codes

Lot #: a) 6624001 exp 2/16, 6630501 exp 3/16, 6669001 exp 12/16, 6676201 exp 1/17, 6680701 exp 2/17; b) 6624002, 6624201 exp 2/16, 6630601 exp 3/16, 6668901 exp 12/16, 6676001, 6676101 exp 1/17, 6679401, 6679501, exp 2/17

Where it was sold

Nartionwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1280-2015
Classification
Class II
Status
Terminated
Recall initiated
Jul 9, 2015
FDA report date
Aug 5, 2015
Quantity
a) 96,640 bottles; b) 17,808 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Mutual Pharmaceutical Company, Inc.

Original FDA data

Every field from FDA enforcement report D-1280-2015, exactly as published.

Show all FDA fields
City
Philadelphia
State
PA
Status
Terminated
Country
United States
Event ID
71684
Address
1100 Orthodox St
Code information
Lot #: a) 6624001 exp 2/16, 6630501 exp 3/16, 6669001 exp 12/16, 6676201 exp 1/17, 6680701 exp 2/17; b) 6624002, 6624201 exp 2/16, 6630601 exp 3/16, 6668901 exp 12/16, 6676001, 6676101 exp 1/17, 6679401, 6679501, exp 2/17
Postal code
19124-3168
Report date
Aug 5, 2015
Product type
Drugs
Recall number
D-1280-2015
Classification
Class II
Recalling firm
Mutual Pharmaceutical Company, Inc.
Product quantity
a) 96,640 bottles; b) 17,808 bottles
Termination date
Oct 13, 2016
Reason for recall
cGMP Deviations; Clonidine hydrochloride drug substance used in the manufacturing of this product, was dispensed in unauthorized rooms by the drug substance manufacturer
Voluntary / mandated
Voluntary: Firm initiated
Product description
Clonidine Hydrochloride Tablets, USP, 0.1 mg, packaged in a) 100 count (NDC 53489-215-01) and b) 1000 count (NDC 53489-215-10) HDPE bottles, Rx only, Mutual Pharmaceutical, Philadelphia, PA
Distribution pattern
Nartionwide
Recall initiation date
Jul 9, 2015
Initial firm notification
Letter
Center classification date
Jul 30, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1280-2015, published Aug 5, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls